December 2011 Volume 7, Issue 12
Volume 7, Issue 12 | December 2011
December 2011
In this Issue
Research & Development
Plug-and-play deal
Acute-care therapy developer Cubist Pharmaceuticals to acquire pain management specialist Adolor in deal valued at up to $415 millionMaking a spark, igniting a fire
Michael J. Fox Foundation partners with Kinetics Foundation in search of biomarker in Parkinson’s diseaseTwo heads are better than one
California’s stem cell agency joins forces with NIH to advance stem cell researchAnother brick in the wall
NeoStem closes acquisition of Amorcyte, another step in its drive toward cell therapy focusDone deal times two
ViroPharma agrees to buy DuoCort Pharma weeks before its orphan drug Plenadren is granted European Marketing Authorization for adrenal insufficiencyContract Services
Doing some corporate stock-up shopping
Seeking to fill gaps and extend reach, Quintiles acquires three companies in October and NovemberWuXi buys in its backyard
CRO purchases two China-based clinical research services companiesInjecting strength into the business
Germany’s Evonik buys SurModics Pharmaceuticals to bolster North America presenceRepligen acquires Novozymes Biopharma
Company strengthens position as supplier of products for manufacturing biologic drugs; expects near-term, sustainable profitabilityDesign, make, test
U.K.’s Sygnature Discovery, Saretius launch strategic alliance aimed at treating CNS disorders, inflammatory diseasesOmics & Systems Biology
Getting to the heart of the matter
Servier, miRagen team up on cardiovascular disease therapeuticsA high-'Profile' partnership
Dana-Farber, Brigham and Women's undertake genomics research projectA gram better way to do things
Powerful SomaLogic proteomic technology to be applied to biomarker discovery, target discovery and validation and lead to ‘wellness’ chipStart spreading the news
New York Genome Center launches collaboration of 11 leading medical/research institutionsAdding tools to the toolbox
Horizon, Promega forge predictive disease model pactDiagnostics
Being 'companionable' with new immunotherapy
Life Technologies signs agreement with GlaxoSmithKline Biologicals, seeking expanded use of platform technologies into companion diagnosticsA full work-up for Alzheimer’s disease
Exonhit taps Cleveland Clinic’s Lou Ruvo Center to conduct AclarusDx test for early diagnosis of Alzheimer’s diseasePancreatic cancer biomarkers sought
Oxford Gene Technology and Abcodia combine expertise to search for better biomarkers for the early diagnosis of pancreatic cancerYour halo is showing
Sweden's Halo Genomics and Uppsala University collaborate on study to identify mutations that cause colon cancerGlobal News
Taking direct action
Roche makes $230 million offer for antiviral developer Anadys; shareholders challenge the offer in courtBomb meets bomber in new deal
Oxford BioMedica takes glaucoma research from Mayo Clinic to explosive new level with agreement to develop gene therapyCancer deaths in Korea
Institut Pasteur Korea and Sanofi look for small-molecule antiviral to combat HBVNot ‘immune’ to each other’s charm
Biogen, Portola ink agreement for autoimmune therapeuticsTwo against the flu
Alios BioPharma and Versitech Ltd. announce exclusive worldwide licensing agreement for influenza technologyCommentary
Data management that speeds—rather than impedes—advanced DNA sequencing applications
How labs choose to manage their data may very well determine which have the most success in applying DNA sequencing to the development of advanced molecular diagnostics and therapeutics.On biobanking: Deposits and withdrawals
It is encouraging to see the challenge of well-documented samples being met using electronic medical records to make queries more feasible and less costly.Editor's Focus
Out with the old, in with many new features to ddn
It’s difficult to believe we’re about to put our final issue of 2011 to press, but as we don our gay apparel, pour some celebratory eggnog and give this edition a final polish, we have a rare few moments to pause and reflect on another editorial year gone by.Instruments & Informatics
Taking a new pathway
Caliper, Pfizer launch platform for drug safetyGoing 'Broad' to get specific about cancer
Affymetrix announces cancer-profiling collaboration with the Broad Institute to advance The Cancer Genome AtlasOne assay, 242 genes
RainDance Technologies and Ambry Genetics launch new DNA sequencing panel for ADME researchFinding satisfaction in stratification
Selventa and Linguamatics announce strategic partnership to provide a ‘complete pipeline’ of scientific knowledge extraction to their life science partnersSpecial Reports
The personal side of cell biology
For personalized medicine to truly arrive, cell biology may be more important in the end than genomics
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Thermo Scientific™ Centrifuges with GreenCool Technology
Next-generation natural refrigerant cooling system for centrifuges, offering a lower Global Warming Potential and reduced energy consumption.
The crucial role of sample preparation in biotherapy manufacturing
Discover how better sample preparation can unlock improved assay accuracy and analytical results.
Discovering deeper insights into malaria research
Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
